Moderna executives have profited handsomely by exercising their stock options and dumping their stocks when the stock prices soared after the allegedly promising (actually disastrous) human guinea pig trials.
Jump to content
Posted 27 May 2020 - 04:00 PM
COVID-19 is now a global pandemic. This deadly RNA-virus is taking a toll on millions of lives across the world, since it crept into China in November-December last year, but more so when it co-exists with a bacterial pathogen 'Chlamydia pneumonia', the otherwise, highly infectious, but simple flu-like illness becomes life-threatening.
This 'Chlamydia pneumonia' is present in several heart patients, and around 10 per cent of the general population in the dormant stage. When COVID-19 attacks a person— breaking the immunity quotient—a process of blood coagulation initiates in pulmonary arteries leading to a cardiac arrest or Hypoxia in which the patient succumbs to the dual diseases.
Whether the SARS CoV-2 claims a life in association with a dormant 'Chlamydia pneumonia'?
This is a big question mark in medical science. This project is a new 'hypothesis' too, Dr Jaideep Dogra, MD and in-charge of CGHS in Jaipur and Dr Luvdeep Dogra, DM-F Nephrology at Osmania University said.
Researching 'Chlamydia pneumonia' for over two years on heart patients in Rajasthan, Dr Jaideep also published a paper in the International Journal of General Medicine.
"Eighty-five per cent of Covid-19 patients having normal Influenza-Like Illness (ILI) symptoms get treated, while 10-15 per cent of patients develops sudden breathlessness and land in an emergency. In such patients, C.penumoniae probably gets activated when COVID-19 breaks down the patient's immunity. This bacterial pathogen has a tendency, it gets activated, causes arterial thrombo (coagulopathy)" they said.
Quoting a postmortem study on COVID-19 victims done by Italy, they said: "Autopsy studies on 38 subjects from two hospitals in Italy who died of COVID-19 were systematically analysed. A relevant finding of the presence of platelet-fibrin-thrombosis in small pulmonary arteries, which fits into the clinical context of a ‘Coagulopathy’ was present in a majority of these patients (86.8%, 33 out of 38). And, this was the turning point in the management of COVID 19."
"Similarly, 'Happy hypoxia' of COVID-19 disease in which young patients succumb suddenly as their hypoxia goes unnoticed can be explained by the autopsy reports from young soldiers of Korean War and Vietnam War reporting an incidence of 45-77% of Coronary atherosclerosis in the mean age group of 26 years. This indirectly co-relates with the known observation that chlamydia pneumonia is present in young populations too", they hypothesized.
0 members, 0 guests, 0 anonymous users